Back to Market Feed

REYVOW 100 MG TABLET

lasmiditan
$88.7890per EA
DEA Schedule CV

Strength

100 mg/1

NDC

00002449108

Classification

Brand

Dosage Form

TABLET

Route

ORAL

Last Updated

12/17/2025

Active Ingredients

LASMIDITAN

Approval Type

New Drug (NDA)

FDA Application

NDA211280

On Market Since

10/11/2019

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

-0.1%

1Y

-0.1%

3Y

+0.1%

5Y

+9.7%

All

+15.2%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

No related drugs found.